Search Results 251-260 of 13922 for 78%
About this study. The purpose of this long-term, followup study is to evaluate subjects who have, during the interventional study, received GSK3377794 ...
78 · 79 · 80 · 81 · 82 · 83 · 84 ... Next · Last · Sign up to receive email notifications. Explore more topics. Scroll backwards. Biotherapeutics · Clinical ...
78. 0.3. 0.2. 15. 5. 74. 0. 258. LF Van Yogurt. 148. 2.0. 1.2. 28. 6. 90. 0. 268. Blueberry Greek Yogurt. 110. 0.0. 0.0. 16. 11. 55. 1. 188. Plain FF Greek ...
The American College of Surgeons' National Surgical Quality Improvement Program has recognized Mayo Clinic Hospital – Rochester as one of 78 participating ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Cancer: Managing Symptoms Discussions. needshope78 · Need hope: Neuropathy from chemo. 168 Replies Fri, Mar 20, 2026. jgreg1954 · Phrenic Nerve damage and ...
About this study. A pragmatic randomized clinical trial of patients with locally advanced breast cancer randomized to either proton or photon therapy and ...
78-year-old man with metastatic squamous cell carcinoma, dyspnea, and hypotension. Mayo Clin Proc. 2010 Nov; 85 (11):e78-81. View PubMed; Barton JG, Bois JP ...
78. Dyrbye LN, West CP, Herrin J, Davidio J, Cuningham B, Yeazel M, Lam V, Onyeador IN, Wittlin. NM, Burke SE, Hayes SN, Phelan SM, van Ryn M. A Longitudinal ...
... 78% CRR (95% confidence interval (CI), 62-90) and 89% ORR (95% CI, 75-97). As of 17 May 2021 (median follow-up, 15.9 months), 73% of patients remained in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.